Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin

Pediatrics

Volumn 98, Issue 2, 1996, Pages 211-215

  Jonas, Maureen M ^a,d   Baron, Miriam J ^b   Bresee, Joseph S ^c   Schneider, Lynda C ^d  

^a Center for Childhood Liver Disease   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

blood transfusion; hepatitis C; intravenous immunoglobulin; non A; non B hepatitis

Indexed keywords

IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC HEPATITIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEPATITIS C; HUMAN; IMMUNE DEFICIENCY; LIVER FIBROSIS; MALE; PRIORITY JOURNAL; SCREENING; VIREMIA; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COMMON VARIABLE IMMUNODEFICIENCY; DRUG CONTAMINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS, CHRONIC; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RNA, VIRAL; VIREMIA;

EID: 0029745650     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Simmonds P, Alberti A, Alter HJ, et al. A proposed system of the nomenclature of hepatitis C viral genotypes. Hepatology. 1994;19: 1321-1324
2. WHO Scientific Group. Primary immunodeficiency diseases. Report of a WHO Scientific Group, Immunodef Rev. 1992,3:195-236
3. Bjoro K, Froland SS, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med. 1994;331: 1607-1611
4. Bjorkander J, Cunningham-Rundles C, Lundin P, et al. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med. 1988;84:107-111
5. Lane RS. Non-A, non-B hepatitis from intravenous immunoglobulin Lancet. 1983;2:974-975. Letter
6. Lever AML, Webster ADB, Brown D, Thomas HC. Non-A, non-B hepatitis occurring in agammaglobulinemia patients after intravenous immunoglobulin. Lancet. 1984;2:1062-1064
7. Ochs HD, Fischer SH, Virant FS, et al. Non-A, non-B hepatitis and intravenous immunoglobulin. Lancet. 1985;1:404-405. Letter
8. Weiland O, Mattsson L, Glaumann H. Non-A-B hepatitis after intravenous gammaglobulin. Lancet. 1986;1:976-977. Letter
9. Williams PE, Yap PL, Gillon J, et al. Non-A-B hepatitis transmission by intravenous immunoglobulin. Lancet. 1988;2(8609):501. Letter
10. Mahaney K, Tedeschi V, Maertens G, et al. Genotypic analysis of hepatitis C virus in American patients. Hepatology. 1994;20: 1405-1411
11. Weiner AJ, Geysen HM, Christopherson C, et al. Immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA. 1992;89: 3468-3472
12. Kumar U, Monjardino J, Thomas HC. Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology. 1994;106:1072-1075
13. Webster ADB, Lever AML. Non-A, non-B hepatitis after intravenous gammaglobulin. Lancet. 1986:1:322. Letter
14. Smith MSH, Webster ADB, Dhillon AP, et al. Orthotopic liver transplantation for chronic hepatitis in two patients with common variable immunodeficiency. Gastroenterology. 1995;108:879-884